NEW JERSEY HEALTH Foundation Awards $1.2 Million for Innovative Research

NEW BRUNSWICK, N.J., Jan. 7, 2015 /PRNewswire-USNewswire/ -- NEW JERSEY HEALTH Foundation (NJHF) has awarded grants totaling $1.2 million to advance innovative research in New Jersey.

This round of funding for the NEW JERSEY HEALTH Foundation Research Grant Program was available for faculty members at Rutgers Biomedical and Health Sciences (RBHS), part of Rutgers, The State University of New Jersey.

Twenty-three grants of $35,000 each will provide seed or bridge funding for researchers throughout RBSH who are exploring a variety of areas including:

• Regulation of cancer metabolism;
• Safe use of antipsychotic medications in children and adolescents;
• Control of sepsis;
• Neurotropic agents for treating Parkinson's disease;
• Lyme disease detection;
• Anti-fungal drug development;
• Mechanism of antituberculosis activity of statins.

Three grants of $100,000 and two of $50,000 were awarded to advance research relevant to RBHS signature programs.  Projects will explore:

• An unconventional receptor critically important to cancer development;
• Ways to promote remyelination in multiple sclerosis;
• Better predictors for latent tuberculosis reactivation;
• New pathways to promote immunity and lung health;
• Effects of exposure to traffic-related air pollution among New Jersey commuters.

"We have funded more than $54 million in research grants to affiliated organizations to promote innovative science within New Jersey.  Many of our recipients have gone on to secure external funding from state and federal organizations including the National Institutes of Health to advance these projects," explained George F. Heinrich, M.D., vice chair and CEO. "NEW JERSEY HEALTH Foundation is proud to support these outstanding early stage research projects that may someday lead to innovative medical breakthroughs."

To learn more about future funding opportunities visit www.njhf.org.

NEW JERSEY HEALTH Foundation (www.njhf.org) is a not-for-profit corporation that supports biomedical research and health-related education programs through its Grants Program and has contributed more than $54 million to advance such programs in New Jersey.  Its affiliate, Foundation Venture Capital Group (www.foundationventure.com), makes private equity investments to participate in establishing and managing biomedical start- up companies in New Jersey headed toward commercialization. 

SOURCE NEW JERSEY HEALTH Foundation

Related Links

http://www.njhf.org

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED